RCL
Asset Logo

Readcloud Limited

🇦🇺 ASX

🤖 TECHNOLOGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-14.39%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ReadCloud Ltd. engages in the provision of digital eLearning solutions to Australian secondary schools. The company is headquartered in Brighton, Victoria and currently employs 500 full-time employees. The company went IPO on 2018-02-07. The Company’s eBook platform delivers digital content to students and teachers with functionality, including the ability to make commentary in, and import third party content into eBooks. Students and teachers can share notes, questions, videos and weblinks directly inside the eBooks turning the eBook into a place for discussion, collaboration and social learning. Its ReadCloudVET enables the delivery of 50 qualifications to 15,000 learners across three specialist registered training organizations (RTOs) in vocational education and training delivered to secondary school students. The Company, Southern Solutions Training Services Pty Ltd, offers industry training and delivers flexible, blended training models in the workplace environment for 14 qualifications.

📈 Performance

Price History

-60.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.08

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in RCL

1

📊 Total Capital Earnings

$-170.52

🔃 Average investment frequency

23 weeks

💵 Average investment amount

$501

Last time a customer invested in RCL

249 days
RCL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in RCL also invest in...

Imugene

IMU

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.

🙌 Performance (5Yr p.a)

5.33%

📊 Share price

$0.04 AUD

🧬 BIOTECHNOLOGY

Find Out More

BigTinCan Holdings Ltd. is a global software company, which engages in providing AI-powered sales enablement automation platform. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-03-24. The firm provides an artificial intelligence (AI)-powered sales enablement automation platform. The Company’s principal activity is the provision of an integrated, online platform, Bigtincan Hub, a collaborative and secure solution that automatically delivers the relevant content to the right users directly, across any device and any network. The company provides software as a service (SaaS) application platform, creating a comprehensive solution that offers customers tools for sales content management (Bigtincan Content Hub), sales readiness (Learning Hub) and sales engagement (Engagement Hub), which is engaged in working together to create its Intelligent Enablement Platform (IEP). The firm operates globally with users in over 50 countries and with a solution localized into approximately 40 languages. Its products are used by various companies across the world, with over 2000 deployments and more than one million users.

🙌 Performance (5Yr p.a)

-13.94%

📊 Share price

$0.20 AUD

🤖 TECHNOLOGY

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

🙌 Performance (5Yr p.a)

-13.20%

📊 Share price

$0.06 AUD

🩺 HEALTH CARE

Accent Group Ltd. operates as an investment holding company, which engages in the retail of performance and lifestyle footwear. The company is headquartered in Richmond, Victoria. The company went IPO on 2004-07-07. The firm operates approximately 786 stores and approximately 35 Websites across different retail banners, and distribution rights for 17 international brands across Australia and New Zealand. The firm's geographical segments include Australia and New Zealand. The Company’s banners and brands include The Athlete’s Foot (TAF), Platypus Shoes, Hype DC, Skechers, Merrell, CAT, Vans, Dr. Martens, Saucony, Timberland, HOKA, Superga, Kappa, Palladium, Supra, Subtype, The Trybe, Stylerunner, Glue Store, Autry, and UGG. Its subsidiaries include The Athlete's Foot Australia Pty Ltd, RCG Brands Pty Ltd, RCG Retail Pty Ltd, TAF eStore Pty Ltd, Accent Store Development Pty Ltd, Hype DC Pty Ltd, Subtype Pty Ltd, Accent Active (NZ) Limited, TAF Hornsby Pty Ltd, and Accent Lifestyle (NZ) Limited.

🙌 Performance (5Yr p.a)

3.42%

📊 Share price

$2.26 AUD

🛍️ CONSUMER

💰 HIGH DIVIDEND

📈 HIGH PRICE GROWTH

Arafura Rare Earths Ltd. engages in the exploration and development of mineral resource properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-11-05. The firm produces rare earth products from the Nolans Project. The Nolans Project consists of a mine, process plant, including beneficiation, extraction and separation plants, and related infrastructure to be constructed and located at the Nolans site, approximately 135 kilometers north of Alice Springs in Australia's Northern Territory. Its rare earth products are Neodymium-Praseodymium (NdPr) oxide, and Mixed middle-heavy rare earths (SEG/HRE) oxide. NdPr oxide is the Company's flagship product, which is used by magnet and magnet alloy customers. The Company’s primary products from the Nolans project are rare earths, which are used in catalytic converters in automobiles, consumer electronics, energy efficiency lighting, optics, alloys, advanced ceramics and permanent magnets that enable e-mobility and renewable energy applications.

🙌 Performance (5Yr p.a)

4.44%

📊 Share price

$0.11 AUD

⛏️ MINING

Want more shares? Try these...

Rincon Resources Ltd. provides exploration and mining services. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-12-21. The company has 100% interest in three exploration assets that are prospective for copper, gold, Nb, REEs, and other critical metals. The West Arunta Project consists of a single granted exploration license and three exploration license applications, encompassing over 200 square kilometers (km2) of the highly prospective Central Australian Suture (CAS) zone in the West Arunta Province of Western Australia. Its South Telfer Project consists of six exploration licenses and two prospecting licenses covering over 540 km2 and over 40 km strike of prospective geology known to host gold and copper mineralization. Its Laverton Gold Project consists of two granted exploration licenses and three exploration license applications covering approximately 41 km2 of prospective Banded Iron Formation stratigraphy, within the Mt Margaret-Murrin Greenstone belt.

📊 Share price

$0.01 AUD

⛏️ MINING

Reef Casino Trust engages in the ownership and management of the Reef Hotel Casino. The company is headquartered in Brisbane, Queensland. The Trust has investment in the Reef Hotel Casino. The Trust is the owner and lessor of the Reef Hotel Casino complex in Cairns, North Queensland, Australia. Reef Hotel Casino operates gaming machines, gambling tables, plus Club Prive, TAB, and Keno. The Pullman Reef Hotel Casino provides luxury guest rooms and facilities swimming pool and spa, a health club, and a tour desk. The responsible entity and operator of the Trust is Reef Corporate Services Limited.

🙌 Performance (5Yr p.a)

2.46%

📊 Share price

$2.92 AUD

🏨 HOTELS, RESTAURANTS & LEISURE

💰 HIGH DIVIDEND

RCB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide a total return before costs and tax, in line with DBIQ 0-4 year Investment Grade Australian Corporate Bond Index over the long term

🙌 Performance (5Yr p.a)

-0.52%

📊 Share price

$20.14 AUD

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-01-15. The firm's anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company's anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are water soluble at all pH levels in their liquid form.

🙌 Performance (5Yr p.a)

7.38%

📊 Share price

$0.45 AUD

📈 HIGH PRICE GROWTH

📦 LOGISTICS

Compare
Add to watchlist